Since TTFields is standard for GBM at many institutions, future studies could focus on comparing immune effects of TTFields plus TMZ to TTFields alone in MGMT-unmethylated GBM, which is resistant to TMZ (1) but not TTFields (81). The gene discussed is MGMT; the disease is glioblastoma.